MX2017013047A - Tratamiento de dolor. - Google Patents
Tratamiento de dolor.Info
- Publication number
- MX2017013047A MX2017013047A MX2017013047A MX2017013047A MX2017013047A MX 2017013047 A MX2017013047 A MX 2017013047A MX 2017013047 A MX2017013047 A MX 2017013047A MX 2017013047 A MX2017013047 A MX 2017013047A MX 2017013047 A MX2017013047 A MX 2017013047A
- Authority
- MX
- Mexico
- Prior art keywords
- pain
- treatment
- imidazo
- tetrahydro
- carboxylate
- Prior art date
Links
- AMIPLQUGEQTRSM-GWCFXTLKSA-N [(3s)-oxolan-3-yl] (4s)-4-propan-2-yl-1,4,6,7-tetrahydroimidazo[4,5-c]pyridine-5-carboxylate Chemical compound N1([C@H](C=2N=CNC=2CC1)C(C)C)C(=O)O[C@H]1CCOC1 AMIPLQUGEQTRSM-GWCFXTLKSA-N 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Anesthesiology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1507048.5A GB201507048D0 (en) | 2015-04-24 | 2015-04-24 | Treatment of pain |
| PCT/GB2016/051122 WO2016170353A1 (en) | 2015-04-24 | 2016-04-22 | Treatment of pain |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2017013047A true MX2017013047A (es) | 2017-12-08 |
Family
ID=53488643
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2017013047A MX2017013047A (es) | 2015-04-24 | 2016-04-22 | Tratamiento de dolor. |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US20180104223A1 (enExample) |
| EP (1) | EP3285767B8 (enExample) |
| JP (2) | JP2018520984A (enExample) |
| KR (1) | KR20170139047A (enExample) |
| CN (1) | CN107530330A (enExample) |
| AU (1) | AU2016252237B2 (enExample) |
| BR (1) | BR112017019337A2 (enExample) |
| CA (1) | CA2979160A1 (enExample) |
| DK (1) | DK3285767T3 (enExample) |
| EA (1) | EA032512B1 (enExample) |
| ES (1) | ES2720035T3 (enExample) |
| GB (1) | GB201507048D0 (enExample) |
| HK (1) | HK1249865B (enExample) |
| HU (1) | HUE043871T2 (enExample) |
| IL (1) | IL254155B (enExample) |
| MX (1) | MX2017013047A (enExample) |
| PL (1) | PL3285767T3 (enExample) |
| PT (1) | PT3285767T (enExample) |
| SG (1) | SG11201707870SA (enExample) |
| TR (1) | TR201905392T4 (enExample) |
| WO (1) | WO2016170353A1 (enExample) |
| ZA (1) | ZA201705847B (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201304526D0 (en) | 2013-03-13 | 2013-04-24 | Proximagen Ltd | New compounds |
| GB201507036D0 (en) * | 2015-04-24 | 2015-06-10 | Proximagen Ltd | Crystalline enzyme inhibitor compound |
| GB201507031D0 (en) * | 2015-04-24 | 2015-06-10 | Proximagen Ltd | New pharmaceutical salt forms |
| US20180360808A1 (en) * | 2015-12-07 | 2018-12-20 | Benevolentai Cambridge Limited | Vap-1 inhibitors for treating pain |
| GB201618029D0 (en) | 2016-10-25 | 2016-12-07 | Proximagen Ltd | New process |
| GB201709136D0 (en) * | 2017-06-08 | 2017-07-26 | Proximagen Ltd | New therapeutic uses of enzyme inhibitors |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1993023023A1 (en) * | 1992-05-15 | 1993-11-25 | University Of Saskatchewan | Method for preventing endothelium damage in mammals and for alleviating pain associated with gout and arthritis |
| EP1791835A2 (en) * | 2004-09-09 | 2007-06-06 | Astellas Pharma Inc. | Thiazole derivatives having vap-1 inhibitory activity |
| US20070066646A1 (en) * | 2005-08-02 | 2007-03-22 | Genmedica Therapeutics Sl | Compounds for Inhibiting Copper-Containing Amine Oxidases and Uses Thereof |
| EP3461499A1 (en) | 2006-06-07 | 2019-04-03 | The Board of Trustees of The Leland Stanford Junior University | Anti-leukocyte recruitment therapy for the treatment of recurrence of epileptic seizures |
| TWI490214B (zh) * | 2008-05-30 | 2015-07-01 | 艾德克 上野股份有限公司 | 苯或噻吩衍生物及該等作為ｖａｐ－１抑制劑之用途 |
| MX2011002581A (es) * | 2008-09-16 | 2011-04-07 | Proximagen Ltd | Compuestos nuevos i. |
| FI20115234A0 (fi) * | 2011-03-08 | 2011-03-08 | Biotie Therapies Corp | Uusia pyridatsinoni- ja pyridoniyhdisteitä |
| CA2915163A1 (en) * | 2013-06-12 | 2014-12-18 | Proximagen Limited | New therapeutic uses of enzyme inhibitors |
| HUE042625T2 (hu) * | 2014-04-15 | 2019-07-29 | Pecsi Tudomanyegyetem | Szemikarbazid-szenzitiv amin-oxidáz gátlók fájdalomcsillapítóként való alkalmazásra traumás neuropátiában és neurogén gyulladásban |
| GB201507036D0 (en) * | 2015-04-24 | 2015-06-10 | Proximagen Ltd | Crystalline enzyme inhibitor compound |
| GB201507031D0 (en) * | 2015-04-24 | 2015-06-10 | Proximagen Ltd | New pharmaceutical salt forms |
-
2015
- 2015-04-24 GB GBGB1507048.5A patent/GB201507048D0/en not_active Ceased
-
2016
- 2016-04-22 SG SG11201707870SA patent/SG11201707870SA/en unknown
- 2016-04-22 HK HK18109397.0A patent/HK1249865B/en not_active IP Right Cessation
- 2016-04-22 CN CN201680023299.XA patent/CN107530330A/zh active Pending
- 2016-04-22 AU AU2016252237A patent/AU2016252237B2/en not_active Ceased
- 2016-04-22 PL PL16718885T patent/PL3285767T3/pl unknown
- 2016-04-22 EP EP16718885.3A patent/EP3285767B8/en active Active
- 2016-04-22 DK DK16718885.3T patent/DK3285767T3/en active
- 2016-04-22 HU HUE16718885A patent/HUE043871T2/hu unknown
- 2016-04-22 TR TR2019/05392T patent/TR201905392T4/tr unknown
- 2016-04-22 ES ES16718885T patent/ES2720035T3/es active Active
- 2016-04-22 MX MX2017013047A patent/MX2017013047A/es unknown
- 2016-04-22 WO PCT/GB2016/051122 patent/WO2016170353A1/en not_active Ceased
- 2016-04-22 PT PT16718885T patent/PT3285767T/pt unknown
- 2016-04-22 CA CA2979160A patent/CA2979160A1/en active Pending
- 2016-04-22 BR BR112017019337-0A patent/BR112017019337A2/pt not_active Application Discontinuation
- 2016-04-22 EA EA201792123A patent/EA032512B1/ru not_active IP Right Cessation
- 2016-04-22 KR KR1020177032024A patent/KR20170139047A/ko not_active Withdrawn
- 2016-04-22 US US15/567,555 patent/US20180104223A1/en not_active Abandoned
- 2016-04-22 JP JP2017555657A patent/JP2018520984A/ja active Pending
-
2017
- 2017-08-24 IL IL254155A patent/IL254155B/en active IP Right Grant
- 2017-08-28 ZA ZA2017/05847A patent/ZA201705847B/en unknown
-
2021
- 2021-01-28 JP JP2021012097A patent/JP2021073257A/ja not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| JP2018520984A (ja) | 2018-08-02 |
| DK3285767T3 (en) | 2019-04-29 |
| PL3285767T3 (pl) | 2019-09-30 |
| ES2720035T3 (es) | 2019-07-17 |
| IL254155A0 (en) | 2017-10-31 |
| CA2979160A1 (en) | 2016-10-27 |
| GB201507048D0 (en) | 2015-06-10 |
| HK1249865B (en) | 2019-12-06 |
| AU2016252237A1 (en) | 2017-10-05 |
| WO2016170353A1 (en) | 2016-10-27 |
| KR20170139047A (ko) | 2017-12-18 |
| HUE043871T2 (hu) | 2019-09-30 |
| EP3285767A1 (en) | 2018-02-28 |
| BR112017019337A2 (pt) | 2018-06-05 |
| EA032512B1 (ru) | 2019-06-28 |
| TR201905392T4 (tr) | 2019-05-21 |
| EA201792123A1 (ru) | 2018-03-30 |
| JP2021073257A (ja) | 2021-05-13 |
| PT3285767T (pt) | 2019-05-20 |
| SG11201707870SA (en) | 2017-11-29 |
| CN107530330A (zh) | 2018-01-02 |
| IL254155B (en) | 2021-02-28 |
| AU2016252237B2 (en) | 2021-04-08 |
| EP3285767B8 (en) | 2019-05-22 |
| EP3285767B1 (en) | 2019-03-20 |
| ZA201705847B (en) | 2020-03-25 |
| US20180104223A1 (en) | 2018-04-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA201708692B (en) | Antibacterial compounds | |
| MX378273B (es) | Compuestos activos hacia bromodominios. | |
| PH12020500371A1 (en) | Spirocycle compounds and methods of making and using same | |
| GB2541571A (en) | Pharmaceutical compositions | |
| PH12015502788A1 (en) | Antibody formulations and methods | |
| PH12020500372A1 (en) | Spirocycle compounds and methods of making and using same | |
| CL2015002897A1 (es) | Inhibidores de bace1 | |
| MX2021010886A (es) | Uso de medicamentos para disminuir la evolucion de la enfermedad de parkinson. | |
| EP4289820A3 (en) | Compounds for use in treating alzheimer's disease in apoe4+/+ patients | |
| IL254155B (en) | (3s)-tetrahydro[verne-3-yl (s4)-4-isopropyl-1, 4, 6, 7-tetrahydro-5h-imidazo (4, 5-c)pyridine-5-carboxylate for use in pain treatment | |
| MX379359B (es) | Derivados de 8-amino-2-oxo-1,3-diaza-espiro-[4.5]-decano. | |
| CY1119532T1 (el) | (s)-πιρλινδολη και τα φαρμακευτικως αποδεκτα αλατα αυτης για χρηση στην ιατρικη | |
| UA117933C2 (uk) | Поліпептид, здатний зв'язувати с5-компонент комплементу людини | |
| PH12016501838A1 (en) | Compounds and their methods of use | |
| CY1119522T1 (el) | (r)- πιρλινδολη και τα φαρμακευτικως αποδεκτα αλατα αυτης για χρηση στην ιατρικη | |
| ZA201907017B (en) | Combination therapy for use in treating retroviral infection | |
| IL258316A (en) | A combination of trazodone and gabapentin for the treatment of pain | |
| SG10201903630UA (en) | Iminosugars useful for the treatment of viral diseases | |
| IL268265B (en) | 3-beta-hydroxy-5-alpha-paragnane-20-one for use in medical treatment | |
| UA115417U (xx) | Спосіб профілактики та лікування гіпоксичних змін при карбоперитонеумі | |
| MA39718A (fr) | Compositions et méthodes d'utilisation de celles-ci | |
| GB2546703A (en) | Compounds | |
| HK1240079A1 (en) | Method for treating hyperhidrosis | |
| UA100460U (uk) | Застосування препарату ноофен як засобу лікування еректильної дисфункції в моно- або комплексній терапії |